Electromed Inc (ELMD) - Total Liabilities
Based on the latest financial reports, Electromed Inc (ELMD) has total liabilities worth $9.47 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Electromed Inc to track the company's year-over-year net asset growth rate.
Electromed Inc - Total Liabilities Trend (2008–2025)
This chart illustrates how Electromed Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Electromed Inc to measure how efficiently the company converts operating cash flow to free cash.
Electromed Inc Competitors by Total Liabilities
The table below lists competitors of Electromed Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Solara Active Pharma Sciences Limited
NSE:SOLARA
|
India | Rs10.36 Billion |
|
Tianyu Ecology & Landscape Co
SHG:603717
|
China | CN¥2.29 Billion |
|
Vestel Beyaz Esya Sanayi ve Ticaret AS
IS:VESBE
|
Turkey | TL42.50 Billion |
|
Village Farms International Inc
NASDAQ:VFF
|
USA | $97.10 Million |
|
Motorcar Parts of America Inc
NASDAQ:MPAA
|
USA | $732.76 Million |
|
Mildef Crete
TWO:3213
|
Taiwan | NT$1.08 Billion |
|
GE Power India Limited
NSE:GEPIL
|
India | Rs16.96 Billion |
|
Condor Energies Inc.
TO:CDR
|
Canada | CA$86.14 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Electromed Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ELMD company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Electromed Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Electromed Inc (2008–2025)
The table below shows the annual total liabilities of Electromed Inc from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $10.59 Million | +37.77% |
| 2024-06-30 | $7.69 Million | -5.53% |
| 2023-06-30 | $8.14 Million | +13.18% |
| 2022-06-30 | $7.19 Million | +53.23% |
| 2021-06-30 | $4.69 Million | +56.69% |
| 2020-06-30 | $2.99 Million | -17.27% |
| 2019-06-30 | $3.62 Million | -23.68% |
| 2018-06-30 | $4.74 Million | +18.78% |
| 2017-06-30 | $3.99 Million | -5.57% |
| 2016-06-30 | $4.23 Million | +21.45% |
| 2015-06-30 | $3.48 Million | +13.35% |
| 2014-06-30 | $3.07 Million | -15.36% |
| 2013-06-30 | $3.63 Million | -37.87% |
| 2012-06-30 | $5.84 Million | -5.22% |
| 2011-06-30 | $6.16 Million | -7.75% |
| 2010-06-30 | $6.68 Million | +23.66% |
| 2009-06-30 | $5.40 Million | +0.89% |
| 2008-06-30 | $5.35 Million | -- |
About Electromed Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as we… Read more